|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0840 AUD | +2.44% |
|
+5.00% | -1.18% |
| 02/01 | FDA Denies Neurizon Therapeutics' Request for Fast Track Designation for ALS Treatment Candidate | MT |
| 02/01 | Neurizon Therapeutics says US FDA denies Fast Track designation for NUZ-001 | RE |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition